Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Mol Endocrinol ; 26(1): 87-94, 2012 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-22074949

RESUMO

Enhancing bone morphogenetic protein (BMP) signaling increases bone formation in a variety of settings that target bone repair. However, the role of BMP in the maintenance of adult bone mass is not well understood. Targeted disruption of BMP3 in mice results in increased trabecular bone formation, whereas transgenic overexpression of BMP3 in skeletal cells leads to spontaneous fracture, consistent with BMP3 having a negative role in bone mass regulation. Here we investigate the importance of BMP3 as a mediator of BMP signaling in the adult skeleton. We find that osteoblasts (OBL) and osteocytes are the source of BMP3 in adult bone. Using in vitro cultures of primary bone marrow stromal cells, we show that overexpression of BMP3 suppresses OBL differentiation, whereas loss of BMP3 increases colony-forming unit fibroblasts and colony-forming unit OBL. The ability of BMP3 to affect OBL differentiation is due to its interaction with activin receptor type 2b (Acvr2b) because knockdown of endogenous Acvr2b in bone marrow stromal cells reduces the suppressive effect of BMP3 on OBL differentiation. These findings best fit a model in which BMP3, produced by mature bone cells, acts to reduce BMP signaling through Acvr2b in skeletal progenitor cells, limiting their differentiation to mature OBL. Our data further support the idea that endogenous BMPs have a physiological role in regulating adult bone mass.


Assuntos
Receptores de Activinas Tipo II/metabolismo , Células da Medula Óssea/metabolismo , Proteína Morfogenética Óssea 3/metabolismo , Osteoblastos/metabolismo , Osteogênese , Células Estromais/metabolismo , Receptores de Activinas Tipo II/genética , Animais , Células da Medula Óssea/citologia , Proteína Morfogenética Óssea 3/genética , Diferenciação Celular , Linhagem Celular , Técnicas de Introdução de Genes , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Osteoblastos/citologia , Osteócitos/citologia , Osteócitos/metabolismo , Interferência de RNA , RNA Interferente Pequeno , Transdução de Sinais , Proteínas Smad/metabolismo , Células Estromais/citologia
2.
Nat Med ; 11(6): 623-9, 2005 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-15895073

RESUMO

Anaplastic large cell lymphomas (ALCLs) are caused by chromosomal translocations that juxtapose the anaplastic lymphoma kinase (ALK) proto-oncogene to a dimerization partner, resulting in constitutive expression of ALK and ALK tyrosine kinase activity. One substrate of activated ALK in human ALCLs is the transcription factor Stat3, and its phosphorylation is accurately recapitulated in a new nucleophosmin (NPM)-ALK transgenic mouse model of lymphomagenesis. Here we show by gene targeting that Stat3 is required for the transformation of mouse embryonic fibroblasts in vitro, for the development of B-cell lymphoma in transgenic mice and for the growth and survival of both human and mouse NPM-ALK-transformed B and T cells. Ablation of Stat3 expression by antisense oligonucleotides significantly (P < 0.0001) impaired the growth of human and mouse NPM-ALK tumors in vivo. Pharmacological ablation of Stat3 represents a new candidate approach for the treatment of human lymphoma


Assuntos
Transformação Celular Neoplásica , Proteínas de Ligação a DNA/fisiologia , Linfoma Difuso de Grandes Células B/fisiopatologia , Proteínas Tirosina Quinases/fisiologia , Transativadores/fisiologia , Quinase do Linfoma Anaplásico , Animais , Linhagem Celular , Fibroblastos/fisiologia , Humanos , Linfoma de Células T/fisiopatologia , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Nus , Camundongos Transgênicos , Dados de Sequência Molecular , Mieloma Múltiplo/fisiopatologia , Oligonucleotídeos Antissenso/farmacologia , Proto-Oncogene Mas , Receptores Proteína Tirosina Quinases , Fator de Transcrição STAT3
3.
Immunity ; 17(1): 63-72, 2002 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-12150892

RESUMO

STAT3 has been described as an essential component of G-CSF-driven cell proliferation and granulopoiesis. This notion was tested by conditional gene ablation in transgenic mice. Contrary to expectation, granulocytes developed from STAT3 null bone marrow progenitors, and STAT3 null neutrophils displayed mature effector functions. Rather than a deficit in granulopoiesis, mice lacking STAT3 in their hematopoietic progenitors developed neutrophilia, and bone marrow cells were hyperresponsive to G-CSF stimulation. These studies provide direct evidence for STAT3-independent granulopoiesis and suggest that STAT3 directs a negative feedback loop necessary for controlling neutrophil numbers, possibly through induced expression of the signaling inhibitor, SOCS3.


Assuntos
Proteínas de Ligação a DNA/fisiologia , Fator Estimulador de Colônias de Granulócitos/farmacologia , Granulócitos/fisiologia , Hematopoese , Proteínas Repressoras , Transativadores/fisiologia , Fatores de Transcrição , Animais , Diferenciação Celular , Divisão Celular , Células Cultivadas , Proteínas de Ligação a DNA/genética , Fator Estimulador de Colônias de Granulócitos/antagonistas & inibidores , Granulócitos/citologia , Granulócitos/efeitos dos fármacos , Células-Tronco Hematopoéticas/fisiologia , Camundongos , Camundongos Knockout , Camundongos Transgênicos , Neutrófilos/fisiologia , Biossíntese de Proteínas , Fator de Transcrição STAT3 , Transdução de Sinais , Proteína 3 Supressora da Sinalização de Citocinas , Proteínas Supressoras da Sinalização de Citocina , Transativadores/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA